Venmax Drugs and Pharmaceuticals Limited has intimated BSE Limited about an upcoming Board of Directors meeting scheduled for Friday, August 7, 2026 at 4:00 PM.
The Board will consider two agenda items:
- Approval of the Un-audited Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27)
- Approval of the Forfeiture of partly paid-up share warrants
The company also confirmed that the Trading Window for dealing in securities of the company remains closed for all Designated Persons. The closure period began on July 1, 2026 and will continue until August 9, 2026 (48 hours after the approval of the Unaudited Standalone Financial Results for the quarter ended June 30, 2026).
The communication was digitally signed by Priyanka Agarwal, Company Secretary & Compliance Officer, on August 1, 2026 at 15:31:34 IST.